StandardStandard

The role of health economics in the Stand Together trial: evaluating the cost-effectiveness of KiVa in UK primary schools. / Whiteley, Holly; Edwards, Rhiannon Tudor.
2024. Ffurflen grynodeb Why Bullying Prevention in School Matters, Bangor, Y Deyrnas Unedig.

Allbwn ymchwil: Cyfraniad at gynhadleddCrynodeb

HarvardHarvard

Whiteley, H & Edwards, RT 2024, 'The role of health economics in the Stand Together trial: evaluating the cost-effectiveness of KiVa in UK primary schools', Why Bullying Prevention in School Matters, Bangor, Y Deyrnas Unedig, 20/03/24 - 20/03/24.

APA

CBE

Whiteley H, Edwards RT. 2024. The role of health economics in the Stand Together trial: evaluating the cost-effectiveness of KiVa in UK primary schools. Ffurflen grynodeb Why Bullying Prevention in School Matters, Bangor, Y Deyrnas Unedig.

MLA

VancouverVancouver

Whiteley H, Edwards RT. The role of health economics in the Stand Together trial: evaluating the cost-effectiveness of KiVa in UK primary schools. 2024. Ffurflen grynodeb Why Bullying Prevention in School Matters, Bangor, Y Deyrnas Unedig.

Author

RIS

TY - CONF

T1 - The role of health economics in the Stand Together trial: evaluating the cost-effectiveness of KiVa in UK primary schools

AU - Whiteley, Holly

AU - Edwards, Rhiannon Tudor

PY - 2024/3

Y1 - 2024/3

N2 - We conducted a health economic evaluation of the KiVa anti-bullying programme, alongside the Stand Together trial, to explore its cost-effectiveness for reducing bullying amongst 7-to-11-year-olds in UK primary schools. Our presentation will outline the importance of health economics in contributing to the evidence-base for the KiVa programme and will introduce our approach and methods for costing and evaluating KiVa compared to usual practice.Cost calculations were conducted from an education-sector perspective and included KiVa training and resources plus staff-time preparing and delivering lessons. The estimated costs of KiVa and usual practice will be used in three separate health economic analyses to explore cost-effectiveness;i) a cost-utility analysis exploring the incremental cost of KiVa per incremental pupil-reported quality-adjusted life year (QALY) gained,ii) a cost-effectiveness analysis exploring the incremental cost per incremental bullying incident avoided (BIA), iii) a cost-consequence analysis comparing costs with a wide range of pupil- and teacher outcomes.

AB - We conducted a health economic evaluation of the KiVa anti-bullying programme, alongside the Stand Together trial, to explore its cost-effectiveness for reducing bullying amongst 7-to-11-year-olds in UK primary schools. Our presentation will outline the importance of health economics in contributing to the evidence-base for the KiVa programme and will introduce our approach and methods for costing and evaluating KiVa compared to usual practice.Cost calculations were conducted from an education-sector perspective and included KiVa training and resources plus staff-time preparing and delivering lessons. The estimated costs of KiVa and usual practice will be used in three separate health economic analyses to explore cost-effectiveness;i) a cost-utility analysis exploring the incremental cost of KiVa per incremental pupil-reported quality-adjusted life year (QALY) gained,ii) a cost-effectiveness analysis exploring the incremental cost per incremental bullying incident avoided (BIA), iii) a cost-consequence analysis comparing costs with a wide range of pupil- and teacher outcomes.

M3 - Abstract

T2 - Why Bullying Prevention in School Matters

Y2 - 20 March 2024 through 20 March 2024

ER -